DS Biopharma (Ireland)

Recent papers from DS Biopharma (Ireland)

1. Incidence of medically attended Lyme borreliosis across endemic regions of six European countries (BOLD): a prospective multicentre active surveillance studyThe Lancet Regional Health - Europe · 2026
2. Risk Analysis from the Burden of Lyme Disease (BOLD) StudyPathogens · 2026
3. Clinical Manifestations of Lyme Borreliosis in Europe: Burden of Lyme Disease Study (BOLD), 2021–2022Pathogens · 2026
4. Reading Comprehension in Aphasia: A Review of Research and TreatmentLanguage and Linguistics Compass · 2025
5. Establishing minimally clinically important differences for the orthostatic hypotension questionnaire (OHQ)Clinical Autonomic Research · 2025
6. Exploring the Impact of Caring for an Individual With Neurogenic Orthostatic Hypotension: A Qualitative StudyNeurodegenerative Disease Management · 2023
7. P375 Izencitinib induction treatment in patients with moderately-to-severely-active Crohn’s Disease: A phase 2 double-blind, randomized, placebo-controlled studyJournal of Crohn s and Colitis · 2023
8. Health-related quality-of-life and Burden for Caregivers of Individuals With Neurogenic Orthostatic HypotensionNeurodegenerative Disease Management · 2022
9. Plasma neurofilament light levels associate with muscle mass and strength in middle‐aged and older adults: findings from GenoFitJournal of Cachexia Sarcopenia and Muscle · 2022
10. A US Time and Motion Pilot Study of Nebulized COPD Therapy in an Inpatient and a Long-Term Care SettingPulmonary Therapy · 2022
11. Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trialClinical Autonomic Research · 2021
12. Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotensionClinical Autonomic Research · 2021
13. Development of Gut-Selective Pan-Janus Kinase Inhibitor TD-1473 for Ulcerative Colitis: A Translational Medicine ProgrammeJournal of Crohn s and Colitis · 2020
14. Visual benefit versus visual gain: what is the effect of baseline covariants in the treatment arm relative to the control arm? A pooled analysis of ANCHOR and MARINABritish Journal of Ophthalmology · 2019
15. Pseudophosphatase STYX modulates cell-fate decisions and cell migration by spatiotemporal regulation of ERK1/2Proceedings of the National Academy of Sciences · 2013